Physician profile
Christopher Oh
NPI 1942208889
$16,651.90
in general payments reported to CMS, 2019-2025
43 companies · $3,587 in 2025
The $3,587 reported for 2025 was more than what 89% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,510 · 2020: $721 · 2021: $818 · 2022: $1,797 · 2023: $4,556 · 2024: $3,664 · 2025: $3,587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $1,467 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,319.82 |
| Travel and Lodging | $1,466.62 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,455.32 | 2019-2025 | Triclip, Jot Dx, Accent |
| Novartis Pharmaceuticals Corporation | $1,198.12 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,181.55 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $1,084.80 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Medtronic, INC. | $1,029.81 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Linq II |
| Boston Scientific Corporation | $977.99 | 2021-2025 | Watchman Flx, Watchman, Watchman Access System |
| Pfizer INC. | $754.35 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $753.22 | 2022-2025 | Verquvo, Capvaxive, Lagevrio |
| E.R. Squibb & Sons, L.L.C. | $567.73 | 2019-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $450.56 | 2019-2024 | Xarelto |
| Philips North America LLC | $409.96 | 2022-2025 | (5050) Ext Holter, Extended Holter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $382.03 | 2019-2025 | Jardiance |
| Amgen INC. | $329.43 | 2019-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $299.94 | 2022-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $224.68 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $223.50 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Evoque |
| Medtronic Vascular, INC. | $194.66 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $109.77 | 2022-2025 | |
| Regeneron Healthcare Solutions, INC. | $93.44 | 2019-2023 | Evkeeza |
| Sanofi-Aventis U.S. LLC | $91.22 | 2019-2023 | |
| Arbor Pharmaceuticals, INC. | $75.82 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $74.59 | 2019 | |
| Inari Medical, INC. | $63.82 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Esperion Therapeutics, INC. | $61.85 | 2022-2025 | Nexletol |
| Irhythm Technologies, INC. | $58.19 | 2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $53.74 | 2024 | Arcalyst |
| Bridgebio Pharma, INC. | $45.36 | 2025 | Attruby |
| Otsuka America Pharmaceutical, INC. | $38.98 | 2019 | |
| Abiomed | $35.87 | 2025 | |
| Vifor Pharma, INC. | $30.78 | 2019 | |
| Kestra Medical Technology Services, INC. | $29.92 | 2022 | |
| Becton, Dickinson and Company | $29.87 | 2024 | Arista Ah Flexitip |
| Kiniksa Pharmaceuticals, Ltd. | $25.42 | 2023 | Arcalyst |
| Bracco Diagnostics INC. | $24.93 | 2025 | |
| Blueprint Medicines Corporation | $24.87 | 2021 | |
| Cardiva Medical, INC. | $24.85 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Lundbeck LLC | $24.68 | 2019 | |
| Lilly USA, LLC | $23.89 | 2025 | Mounjaro, Zepbound |
| Genzyme Corporation | $22.35 | 2023 | |
| Scpharmaceuticals INC. | $21.42 | 2025 | |
| Biotronik INC. | $19.79 | 2023 | Biomonitor, Edora 8 Dr-T, Acticor 7 Vr-T Dx |
| Daiichi Sankyo INC. | $15.47 | 2023 | Injectafer |
| Heartflow, INC. | $13.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Oh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.